Table 1. Characteristics of the study population.
n=4292 | |
---|---|
Age range (years) | 0–94 |
Median age | 35 |
Female (%) | 2932 (68) |
Follow-up years (mean, SD) | 4.40 (0.90) |
Tribe (%) | |
Bimoba | 72.0 |
Kusasi | 21.6 |
Other | 6.4 |
Mortality during follow-up | |
All (n, %) | 292 (6.8) |
<5 years (n, %) | 77 (8.0) |
IL10 (pg/ml) (median, IQR) | |
LPS (n=605) | 13 065 (8092–19 714) |
Zymosan (n=604) | 13 032 (8844–18 673) |
TNFα (pg/ml) (median, IQR) | |
LPS (n=605) | 4468 (3212–5960) |
Zymosan (n=604) | 227 (128–398) |
Plasmodium falciparum (n=647) | |
Positives (n, %) | 554 (85.6) |
Median Ct value (IQR) (n=554) | 30.7 (28.3–33.1) |
Abbreviations: IL10, interleukin-10; IQR, interquartile range; LPS, lipopolysaccharide; SD, standard deviation; TNFα, tumor necrosis factor-α.